Cargando…
Effects of PCSK9 Inhibition on Coronary Atherosclerosis Regression of Nontarget Lesions after Primary Percutaneous Coronary Intervention in Acute Coronary Syndrome Patients
AIMS: To evaluate the regression of coronary atherosclerosis with proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibition in acute coronary syndrome (ACS) patients following primary percutaneous coronary intervention (PPCI). Methods and Result. We examined 40 nontarget lesions in 17 ACS pat...
Autores principales: | Li, Yongjun, Yang, Mingming, Chen, Xi, Zhang, Rui, Li, Jing, Zhang, Xiaoguo, Zuo, Pengfei, Ma, Genshan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9807301/ https://www.ncbi.nlm.nih.gov/pubmed/36632288 http://dx.doi.org/10.1155/2022/4797529 |
Ejemplares similares
-
Coronary flow reserve and microcirculatory resistance in patients with coronary tortuosity and without atherosclerosis
por: Li, Yang, et al.
Publicado: (2020) -
Spontaneous left main coronary artery dissection occurred in a young male: a case report and review of literature
por: Li, Yongjun, et al.
Publicado: (2022) -
Sex Differences in Murray Law‐Based Quantitative Flow Ratio Among Patients With Intermediate Coronary Lesions
por: Zuo, Wenjie, et al.
Publicado: (2023) -
Coronary tortuosity is negatively correlated with coronary atherosclerosis
por: Li, Yang, et al.
Publicado: (2018) -
Glycemic variability as predictor of contrast-induced nephropathy in diabetic patients with acute myocardial infarction undergoing percutaneous coronary intervention
por: Zuo, Pengfei, et al.
Publicado: (2020)